Can Subcutaneous Infliximab Replace Dose-Intensified Intravenous Administration in Inflammatory Bowel Disease?

Research output: Contribution to journal › Letter › Other › peer-review

Original language	English
Pages (from-to)	2430-2431
Number of pages	2
Journal	Clinical Gastroenterology and Hepatology
Volume	21
Issue number	9
DOIs	https://doi.org/10.1016/j.cgh.2022.09.015
Publication status	Published - Aug 2023

Access to Document

@article{17cee64c59524e02aa3f7b88180d8620,

title = "Can Subcutaneous Infliximab Replace Dose-Intensified Intravenous Administration in Inflammatory Bowel Disease?",

author = "Little, {Robert D.} and Ward, {Mark G.} and Sparrow, {Miles P.}",

year = "2023",

month = aug,

doi = "10.1016/j.cgh.2022.09.015",

language = "English",

volume = "21",

pages = "2430--2431",

journal = "Clinical Gastroenterology and Hepatology",

issn = "1542-3565",